/NRXS
NRXS Stock - NeurAxis, Inc.
Healthcare|BiotechnologyNASDAQ
$3.22+11.81%
+$0.34 (+11.81%) • Dec 19
69
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.94
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+117.4%upside
Target: $7.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NRXS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$3.19 – $3.25
TARGET (TP)$7.00
STOP LOSS$2.96
RISK/REWARD1:14.5
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta3.13
52W High$6.20
52W Low$1.33
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $2.69M | $2.46M | $2.68M | $2.72M | $1.93M |
| Gross Profit | $2.32M | $2.16M | $2.39M | $2.25M | $1.45M |
| Gross Margin | 86.5% | 87.7% | 88.9% | 82.8% | 75.1% |
| Operating Income | $-7,156,817 | $-6,664,495 | $-3,372,238 | $-2,970,034 | $-4,120,738 |
| Net Income | $-8,241,501 | $-14,626,683 | $-4,780,061 | $-3,028,032 | $-3,726,149 |
| Net Margin | -306.8% | -594.6% | -178.0% | -111.3% | -193.0% |
| EPS | $-1.22 | $-2.32 | $-0.57 | $-0.62 | $-0.80 |
Company Overview
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
NRXSBeat Rate
0%
Last 2 quarters
Avg Surprise
-276.3%
EPS vs Estimate
Beats / Misses
0/2
Last 12 quarters
Latest EPS
$-0.24
Q4 2025
EPS Surprise History
Q2 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
-29.2%
$-0.31vs$-0.24
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 10, 2025 | — | $-0.24 | — | — |
Q3 2025 | Aug 12, 2025 | — | $-0.22 | — | — |
Q2 2025 | May 12, 2025 | $-0.24 | $-0.31 | -29.2% | ✗ MISS |
Q1 2025 | Mar 20, 2025 | — | $-0.21 | — | — |
Q4 2024 | Nov 12, 2024 | — | $-0.25 | — | — |
Q3 2024 | Aug 9, 2024 | — | $-0.42 | — | — |
Q2 2024 | May 20, 2024 | — | $-0.32 | — | — |
Q2 2024 | Apr 16, 2024 | — | $0.29 | — | — |
Q4 2023 | Nov 20, 2023 | $-0.17 | $-1.06 | -523.5% | ✗ MISS |
Q3 2023 | Aug 18, 2023 | — | $-0.37 | — | — |
Q3 2023 | Aug 11, 2023 | — | $-0.35 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.00 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.25 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.18 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.10 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.16 | — | — |
Latest News
NeurAxis shares are trading higher after the company announced new medical policy coverage from a national health insurer for Percutaneous Electrical Nerve Field Stimulation.
📈 PositiveBenzinga•Dec 19, 2025, 02:17 PM
NeurAxis Rolls Out New Medical Policy Coverage For Percutaneous Electrical Nerve Field Stimulation
📈 PositiveBenzinga•Dec 19, 2025, 01:02 PM
NeurAxis Secured VA Federal Supply Schedule Contract, Financial Terms Not Disclosed
📈 PositiveBenzinga•Dec 1, 2025, 12:09 PM
Neuraxis Q3 EPS $(0.24) Misses $(0.17) Estimate, Sales $811.414K Miss $1.000M Estimate
📉 NegativeBenzinga•Nov 10, 2025, 10:53 PM
NeurAxis Receives FDA Clearance For Its Percutaneous Electrical Nerve Field Stimulation Technology To Treat Functional Abdominal Pain And Nausea Associated With Functional Dyspepsia In Patients Aged 8 And Older.
📈 PositiveBenzinga•Oct 24, 2025, 12:06 PM
NeurAxis slides 21%, raises $5M via stock
📉 NegativeSeeking Alpha•May 21, 2025, 11:28 AM
Frequently Asked Questions about NRXS
What is NRXS's current stock price?
NeurAxis, Inc. (NRXS) is currently trading at $3.22 per share. The stock has moved +11.81% today.
What is the analyst price target for NRXS?
The average analyst price target for NRXS is $7.00, based on 1 analyst.
What sector is NeurAxis, Inc. in?
NeurAxis, Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is NRXS's market cap?
NeurAxis, Inc. has a market capitalization of $0.03 billion, making it a small-cap company.
Does NRXS pay dividends?
No, NeurAxis, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCLGN
CollPlant Biotechnologies Ltd.
$1.52
Mkt Cap: $0.0B
CVKD
Cadrenal Therapeutics, Inc. Common Stock
$7.11
Mkt Cap: $0.0B
ENLV
Enlivex Therapeutics Ltd.
$0.83
Mkt Cap: $0.0B
KLTO
Klotho Neurosciences, Inc.
$0.39
Mkt Cap: $0.0B
NERV
Minerva Neurosciences, Inc.
$4.04
Mkt Cap: $0.0B
NRSN
NeuroSense Therapeutics Ltd.
$0.81
Mkt Cap: $0.0B
RLYB
Rallybio Corporation
$0.79
Mkt Cap: $0.0B
SONN
Sonnet BioTherapeutics Holdings, Inc.
$1.26
Mkt Cap: $0.0B
TAOX
TAO Synergies Inc.
$5.03
Mkt Cap: $0.0B
XCUR
Exicure, Inc.
$5.92
Mkt Cap: $0.0B
Explore stocks similar to NRXS for comparison